Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China flag China · Delayed Price · Currency is CNY
21.80
-0.58 (-2.59%)
May 21, 2026, 3:00 PM CST

SHA:688298 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,2512,4503,0814,1656,5976,098
Short-Term Investments
-----31.15
Trading Asset Securities
149.73122.59207.581,0521,161168.07
Cash & Short-Term Investments
2,4002,5723,2895,2177,7586,297
Cash Growth
-18.18%-21.79%-36.95%-32.75%23.19%181.43%
Accounts Receivable
178.1213.67230.17207.74309.361,184
Other Receivables
11.412.7919.1220.773.1353.96
Receivables
189.5226.46249.28228.44382.491,238
Inventory
293.91309.86308.96346.78431.92470.56
Other Current Assets
154.45147.62131.45104.01175.42120.06
Total Current Assets
3,0383,2563,9795,8968,7478,126
Property, Plant & Equipment
2,6222,6452,7412,2611,074481.34
Long-Term Investments
47.4547.8550.2752.3535.5925.45
Goodwill
-----15.41
Other Intangible Assets
866.71883.88690.91478.81481.24111.48
Long-Term Deferred Tax Assets
250.73256.12268.47218.26193.2369.68
Long-Term Deferred Charges
36.7542.1259.7161.0536.327.37
Other Long-Term Assets
30.988.13305.8528.05135.63139.81
Total Assets
6,8937,1398,0958,99610,7048,977
Accounts Payable
386.66481.4515.49600.491,5801,174
Accrued Expenses
41.8365.2672.0368.45218.81175.55
Short-Term Debt
134.96130.55116.78198.22--
Current Portion of Long-Term Debt
121.4511.12300.2250.3--
Current Portion of Leases
--24.615.863.555.84
Current Income Taxes Payable
5.3812.183.413.7717.67606.85
Current Unearned Revenue
27.7237.5230.9934.77339.1471.19
Other Current Liabilities
84.3293.82140.29113.93119.2425.4
Total Current Liabilities
802.32831.861,2041,0862,2782,059
Long-Term Debt
45.01158.99-30050-
Long-Term Leases
24.6825.347.1743.9628.6512.65
Long-Term Unearned Revenue
25.8426.0634.4810.7517.4617.01
Long-Term Deferred Tax Liabilities
0.010.040.230.042.76-
Other Long-Term Liabilities
10.3111.0217.475.73.39-
Total Liabilities
908.181,0531,3031,4462,3812,088
Common Stock
201.6201.6201.6201.6168120
Additional Paid-In Capital
397.98397.89397.89395.42436.32549.21
Retained Earnings
5,6005,6946,2686,7977,5306,201
Treasury Stock
-326.94-326.94-276.95---
Comprehensive Income & Other
21.1626.1254.942.3728.27-12.72
Total Common Equity
5,8945,9936,6457,4368,1636,857
Minority Interest
90.8792.96146.34113.66160.1531.62
Shareholders' Equity
5,9856,0866,7917,5508,3236,889
Total Liabilities & Equity
6,8937,1398,0958,99610,7048,977
Total Debt
326.11325.96488.76608.3382.218.49
Net Cash (Debt)
2,0742,2462,8004,6097,6756,279
Net Cash Growth
-19.28%-19.78%-39.24%-39.95%22.24%180.61%
Net Cash Per Share
10.9311.6714.2422.8438.0831.14
Filing Date Shares Outstanding
191.52190.02193.2201.6201.6201.6
Total Common Shares Outstanding
191.52190.02193.2201.6201.6201.6
Working Capital
2,2362,4242,7754,8106,4696,068
Book Value Per Share
30.7831.5434.4036.8940.4934.01
Tangible Book Value
5,0275,1095,9546,9577,6826,730
Tangible Book Value Per Share
26.2526.8930.8234.5138.1033.38
Buildings
--1,4651,296586.6243.61
Machinery
--437.85360.52262.56177.03
Construction In Progress
--1,134796.48369.99112.45
Source: S&P Global Market Intelligence. Standard template. Financial Sources.